Immunoassay for Glandular Fever Is Preferable to Leukocyte Ratio
|
By LabMedica International staff writers Posted on 19 Jan 2011 |
|
An immunoassay for the detection of infectious mononucleosis heterophile antibodies in whole blood was compared with the ratio of lymphocytes to white cells as diagnostic tests.
The immunoassay was a qualitative membrane strip wherein bovine erythrocyte extracted antigen is coated on the test line region of the strip. The lymphocyte counts and white blood cell ratio was calculated and compared with the monospot result to calculate the sensitivity and specificity at various ratios.
Investigators at the Mater Misericordiae University Hospital, (Dublin, Ireland), analyzed 500 positive and 500 negative monospot tests for glandular fever using "Clearview IM" detection kits (Alere Limited, Stockport, UK). These results were compared with the white cell count differentials and specifically the ratio of lymphocytes to total white cell count. The lymphocyte counts and white blood cell ratio was significantly different in the positive and negative monospot groups. The mean lymphocyte counts to white blood cell ratio in the positive group was 0.49, and the mean lymphocyte to white cell count ratio in the monospot negative group was 0.29.
The authors concluded that there is a significant difference between the lymphocyte count in patients with infectious mononucleosis and those with negative monospot tests. An increased lymphocyte count is associated with a positive monospot results and using a lymphocyte to white cell count ratio of 0.35 or greater had a specificity of 72% a sensitivity of 84% for the detection of glandular fever. A higher ratio will give a greater specificity, but a lower sensitivity, and vice versa. The study was published online in November 2010, in the journal Clinical Otolaryngology.
Glandular fever or infectious mononucleosis is caused by an infection with the Epstein-Barr virus and is characterized by fever, sore throat, and fatigue, along with several other possible signs and symptoms. The peak incidence for the onset of glandular fever is between the ages of 15 and 17 and it is estimated that 90% of adults have been exposed to the virus.
Related Links:
Mater Misericordiae University Hospital
Alere Limited
The immunoassay was a qualitative membrane strip wherein bovine erythrocyte extracted antigen is coated on the test line region of the strip. The lymphocyte counts and white blood cell ratio was calculated and compared with the monospot result to calculate the sensitivity and specificity at various ratios.
Investigators at the Mater Misericordiae University Hospital, (Dublin, Ireland), analyzed 500 positive and 500 negative monospot tests for glandular fever using "Clearview IM" detection kits (Alere Limited, Stockport, UK). These results were compared with the white cell count differentials and specifically the ratio of lymphocytes to total white cell count. The lymphocyte counts and white blood cell ratio was significantly different in the positive and negative monospot groups. The mean lymphocyte counts to white blood cell ratio in the positive group was 0.49, and the mean lymphocyte to white cell count ratio in the monospot negative group was 0.29.
The authors concluded that there is a significant difference between the lymphocyte count in patients with infectious mononucleosis and those with negative monospot tests. An increased lymphocyte count is associated with a positive monospot results and using a lymphocyte to white cell count ratio of 0.35 or greater had a specificity of 72% a sensitivity of 84% for the detection of glandular fever. A higher ratio will give a greater specificity, but a lower sensitivity, and vice versa. The study was published online in November 2010, in the journal Clinical Otolaryngology.
Glandular fever or infectious mononucleosis is caused by an infection with the Epstein-Barr virus and is characterized by fever, sore throat, and fatigue, along with several other possible signs and symptoms. The peak incidence for the onset of glandular fever is between the ages of 15 and 17 and it is estimated that 90% of adults have been exposed to the virus.
Related Links:
Mater Misericordiae University Hospital
Alere Limited
Gold Member
Troponin T QC
Troponin T Quality Control
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
High Performance Centrifuge
CO336/336R
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
